107 related articles for article (PubMed ID: 521060)
21. Clonal analysis of cytolytic T lymphocyte-mediated lysis of target cells with inducible antigen expression: correlation between antigen density and requirement for Lyt-2/3 function.
Shimonkevitz R; Luescher B; Cerottini JC; MacDonald HR
J Immunol; 1985 Aug; 135(2):892-9. PubMed ID: 2409156
[TBL] [Abstract][Full Text] [Related]
22. Afferent and efferent cellular interactions in natural resistance directed against MHC class I deficient tumor grafts.
Ljunggren HG; Ohlén C; Höglund P; Yamasaki T; Klein G; Kärre K
J Immunol; 1988 Jan; 140(2):671-8. PubMed ID: 3335786
[TBL] [Abstract][Full Text] [Related]
23. [Comparative analysis of the sensitivity to natural killers and macrophages of 3-methylcholanthrene-induced tumors in mice].
Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
Eksp Onkol; 1986; 8(6):36-40. PubMed ID: 3803287
[TBL] [Abstract][Full Text] [Related]
24. H-2 antigens and tumour-associated transplantation antigens in clones derived from a methylcholanthrene-induced BALB/c tumour: their influence on the generation in vitro and in vivo of the specific anti-tumour immune response.
Pérez M; Garrido A; Algarra I; Caballero A; Delgado C; Collado MD; Fernández-Cruz E; Garrido F
Exp Clin Immunogenet; 1989; 6(3):204-18. PubMed ID: 2631798
[TBL] [Abstract][Full Text] [Related]
25. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
Fuyama S; Yamamoto H; Fujii Y; Arai S
Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
[TBL] [Abstract][Full Text] [Related]
27. In vivo modulation of thymus-derived lymphocytes with monoclonal antibodies in mice. III. Spontaneous and natural cytotoxic effector cells.
Herbert AG; Le Gros GS; Bidawid S; Watson JD
Immunology; 1984 Feb; 51(2):377-85. PubMed ID: 6607213
[TBL] [Abstract][Full Text] [Related]
28. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
[TBL] [Abstract][Full Text] [Related]
29. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
30. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
Ogata M; Shimizu J; Tsuchida T; Takai Y; Fujiwara H; Hamaoka T
J Immunol; 1986 Feb; 136(4):1178-85. PubMed ID: 2935573
[TBL] [Abstract][Full Text] [Related]
31. Studies on the immune response to fixed antigens. III. Induction of helper function for antibody-dependent cellular cytotoxicity responses.
Leshem B; Naor D
J Immunol; 1978 Aug; 121(2):401-8. PubMed ID: 681740
[TBL] [Abstract][Full Text] [Related]
32. Increased sensitivity to MHC-nonrestricted lysis of BL6 melanoma cells by transfection with class I H-2Kb gene.
Gorelik E; Jay G; Kwiatkowski B; Herberman RB
J Immunol; 1990 Sep; 145(5):1621-32. PubMed ID: 2384672
[TBL] [Abstract][Full Text] [Related]
33. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
Karlhofer FM; Ribaudo RK; Yokoyama WM
Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
[TBL] [Abstract][Full Text] [Related]
34. Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii.
Hauser WE; Sharma SD; Remington JS
J Immunol; 1983 Jul; 131(1):458-63. PubMed ID: 6190921
[TBL] [Abstract][Full Text] [Related]
35. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
36. Naturally occurring cell-mediated cytotoxicity against simian virus 40-transformed 3T3 murine tumor cells.
Kanar MC; Winkelstein A; Platt D
J Natl Cancer Inst; 1983 Feb; 70(2):267-73. PubMed ID: 6296520
[TBL] [Abstract][Full Text] [Related]
37. Active suppression of host-vs-graft reaction in pregnant mice. VI. Soluble suppressor activity obtained from decidua of allopregnant mice blocks the response to IL 2.
Clark DA; Chaput A; Walker C; Rosenthal KL
J Immunol; 1985 Mar; 134(3):1659-64. PubMed ID: 3871455
[TBL] [Abstract][Full Text] [Related]
38. Studies on the induction and expression of T cell-mediated immunity. X. Inhibition by Lyt 2,3 antisera of cytotoxic T lymphocyte-mediated antigen-specific and -nonspecific cytotoxicity: evidence for the blocking of the binding between T lymphocytes and target cells and not the post-binding cytolytic steps.
Fan J; Ahmed A; Bonavida B
J Immunol; 1980 Dec; 125(6):2444-53. PubMed ID: 6159409
[No Abstract] [Full Text] [Related]
39. Murine in vitro antigenic modification of tumor cells: effect on susceptibility to natural cell-mediated cytotoxicity.
Langweiler M; Weinhold KJ; Matthews TJ; Bolognesi DP
J Natl Cancer Inst; 1985 Mar; 74(3):699-704. PubMed ID: 2983140
[TBL] [Abstract][Full Text] [Related]
40. The induction of cytolytic T lymphocytes with purified plasma membranes.
Lemonnier F; Mescher TM; sherman L; Burakoff S
J Immunol; 1978 Apr; 120(4):1114-20. PubMed ID: 76660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
